Login / Signup

New strategy to resume and taper epoprostenol after lung transplant for pulmonary hypertension.

Akihiro OhsumiAkihiro AoyamaHideyuki KinoshitaTomoya YonedaKazuhiro YamazakiSatona TanakaDaisuke NakajimaTadashi IkedaKenji MinatoyaHiroshi Date
Published in: General thoracic and cardiovascular surgery (2022)
To resume and taper epoprostenol administration after reperfusion in patients with severe PH may be a valuable new strategy associated with better perioperative outcomes.
Keyphrases